X He, Y Wei, S Wang, J Zhang,
Y Gao, S Qian… - Pharmaceutical …, 2022 - Springer
Honokiol (HK), a BCS class II drug with a wide range of pharmacological activities, has poor
solubility and low oral bioavailability, severely limiting its clinical application. In the current …